Editor, – The editorial by Robert Moulds and Melanie Jeyasingham (Aust Prescr 2010;33:134-5) states that 'For ongoing directed gentamicin therapy, other monitoring recommendations remain unchanged'.
Could the authors kindly clarify this statement, that is, what other recommendations remain unchanged, and unchanged compared to what?
Grace Abdini
Senior clinical pharmacist
Pharmacy department
Mount Druitt Hospital, NSW